New drug shows promise for stubborn hand eczema

NCT ID NCT06283550

Completed Disease control Sponsor: Innovaderm Research Inc. Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 18, 2026 · Updated 31 times

Summary

This study tested a medication called abrocitinib in 82 adults with moderate to severe chronic hand eczema that did not improve with steroid creams. The goal was to see if the drug can reduce symptoms like redness, scaling, and itching. Participants were randomly assigned to receive either the drug or a placebo, and researchers measured changes in skin condition over time.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

INNO-6052 Site 11

Montreal, Quebec, H2X 2V1, Canada
INNO-6052 Site 12

Fredericton, New Brunswick, E3B 1G9, Canada
INNO-6052 Site 13

Cobourg, Ontario, K9A 0Z4, Canada
INNO-6052 Site 15

Pomorskie, Poland
INNO-6052 Site 16

Warsaw, Poland
INNO-6052 Site 17

Lodz, Poland
INNO-6052 Site 18

Osielsko, Poland
INNO-6052 Site 19

Krakow, Poland
INNO-6052 Site 20

Szczecin, Poland
INNO-6052 Site 21

Lublin, Poland
INNO-6052 Site 22

Wroclaw, Poland
INNO-6052 Site 23

Mikołów, Poland

Conditions

Explore the condition pages connected to this study.

CHRONIC HAND ECZEMA